With lots of ASX shares to choose from on the Australian market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are outlined below. Let's see why they are bullish on them.
Image Source: Getty Images
Breville Group Ltd (ASX: BRG)
According to a note out of Citi, its analysts have retained their buy rating and $39.85 price target on this appliance manufacturer's shares. The broker highlights that one of Breville's rivals has released a quarterly update which it believes has positive takeaways. It points out that the update revealed that the coffee market has remained strong in the Americas, which bodes well for Breville. In fact, despite the tough economic environment, Citi points out that the rival's growth rate has strengthened since the release of its previous quarterly update. In light of this, the broker appears confident that Breville will deliver on expectations and sees value in its shares at current levels. The Breville share price last traded at $33.82.
CSL Ltd (ASX: CSL)
A note out of UBS reveals that its analysts have retained its buy rating and $158.00 price target on this biotechnology giant's shares. The broker has also been looking at a rival's recent update and believes it points to robust demand in the immunoglobulin market. And while CSL's performance has been disappointing this year, UBS believes that it will pick up in FY 2027 and is expecting the company to win back market share from rivals. Another positive is that it is seeing early signs of a recovery in the albumin market. The CSL share price was fetching $128.83 at yesterday's close.
Life360 Inc. (ASX: 360)
Analysts at Macquarie have retained their outperform rating on this location technology company's shares with a trimmed price target of $31.10. According to the note, the broker believes that recent hiring activity suggests that Life360 is building out its advertising business. This could support strong revenue growth from this side of the business in FY 2027. In addition, Macquarie believes that the recent launch of an Apple Watch app from Life360 could be supportive of subscription growth in the second half of the year. The Life360 share price last traded at $28.47.
